ZeCardio Therapeutics (ZeCardioTx) is a pharma company that specializes in cardiovascular drugs. It uses the zebrafish model and its proprietary screening and analysis platform (ZeCardio) to promote the discovery of therapeutic molecules. The platform combines robotic microfluidic and imaging equipment to analyze the impact of drugs and genetic conditions on cardiac and vascular function in the zebrafish larvae.